Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome Editing of Monogenic Neuromuscular Diseases

26 Sept 2016

Abstract excerpt

IMPORTANCE: Muscle weakness, the most common symptom of neuromuscular disease, may result from muscle dysfunction or may be caused indirectly by neuronal and neuromuscular junction abnormalities. To date, more than 780 monogenic neuromuscular diseases, linked to 417 different genes, have been identified in humans. Genome-editing methods, especially the CRISPR (clustered regularly interspaced short palindromic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to CRISPR and Genetic Engineering
Share to Genetic Neurodegenerative Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27668807
DOI: 10.1001/jamaneurol.2016.3388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome Editing of Monogenic Neuromuscular DiseasesPMID 27668807Read ↗

Correction of muscular dystrophies by CRISPR gene editing.Semantic proximity Read ↗

Making gene editing a therapeutic realitySemantic proximity Read ↗

CRISPR/Cas correction of muscular dystrophies.Semantic proximity Read ↗

Neuromuscular disease: CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy.Semantic proximity Read ↗

CRISPR Therapeutics for Duchenne Muscular DystrophySemantic proximity Read ↗

Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging TherapiesSemantic proximity Read ↗

Precision rewriting of muscle genetics: therapeutic horizons of base and prime editing in skeletal muscle disorders.Semantic proximity Read ↗

Duchenne muscular dystrophy: an updated review of common available therapiesSemantic proximity Read ↗

Methods of CRISPR/Cas9 Exon Skipping for Duchenne Muscular DystrophySemantic proximity Read ↗

Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applicationsSemantic proximity Read ↗

CRISPR technologies for the treatment of Duchenne muscular dystrophy.Semantic proximity Read ↗

Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.